Bibliographic citations
Asencios, P., Ruiz, C. (2022). Evaluación del neurodesarrollo en infantes nacidos de madres infectadas por el virus SARS-CoV-2 en dos hospitales de Lima, Perú [Universidad Peruana Cayetano Heredia]. https://hdl.handle.net/20.500.12866/12230
Asencios, P., Ruiz, C. Evaluación del neurodesarrollo en infantes nacidos de madres infectadas por el virus SARS-CoV-2 en dos hospitales de Lima, Perú []. PE: Universidad Peruana Cayetano Heredia; 2022. https://hdl.handle.net/20.500.12866/12230
@misc{renati/910444,
title = "Evaluación del neurodesarrollo en infantes nacidos de madres infectadas por el virus SARS-CoV-2 en dos hospitales de Lima, Perú",
author = "Ruiz Sánchez, Carlos Andrés",
publisher = "Universidad Peruana Cayetano Heredia",
year = "2022"
}
to be an agent capable of triggering an intrauterine infection, but not a congenital syndrome. In addition, the compromise in neurodevelopment that this virus may have on children is unknown. Objective: To describe the neurodevelopment of children under 6 months of age born to mothers with SARS-CoV-2 virus infection. Materials and methods: A descriptive, cross-sectional secondary study was carried out using the ZIKAlliance database (SIDISI 203249). Data on weight, height, head circumference, scores from the Ages and Stages Questionnaire Third Edition (ASQ-3) and brain ultrasound results were accessed. They were classified into 3 groups: Group A (0 to 2 months), Group B (2 to 4 months) and Group C (4 to 6 months). Results: 90 children were selected, of which 78 were born at term, 10 preterm and 2 post-term. 54% (49/90) were women. 11.1% (8/72) were microcephalic and 5.6% (4/72) macrocephalic. The scores for the domains of communication, gross motor, fine motor, problem solving and socio-individual for group A were 45.7, 50.9, 47.4, 44.0 and 47.3; for group B 50.2, 50.2, 50.2, 48.8 and 48.6, and for group C 55.4, 51.8, 53.9, 56.4 and 53.9, respectively. 25.3% (18/71) had an abnormal finding on brain ultrasound, the most frequent (9/18) being the wide subarachnoid space. Conclusions: Neurodevelopmental surveillance in children younger than 6 months of age with ASQ-3 post perinatal exposure to SARS-CoV 2 did not show developmental delays in any domain.
This item is licensed under a Creative Commons License